Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · IEX Real-Time Price · USD
12.29
+3.18 (34.91%)
At close: Jul 26, 2024, 4:00 PM
11.50
-0.79 (-6.43%)
After-hours: Jul 26, 2024, 7:40 PM EDT
RGC Market Cap
RGC has a market cap or net worth of $159.93 million as of July 26, 2024. Its market cap has decreased by -44.14% in one year.
Market Cap
159.93M
Enterprise Value
148.83M
1-Year Change
-44.14%
Ranking
Category
Stock Price
$12.29
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $159.93M, an increase of 33.16%. That is a compound annual growth rate of 9.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 118.50M | -13.25% |
| Dec 29, 2023 | 136.60M | -62.36% |
| Dec 30, 2022 | 362.90M | -9.88% |
| Dec 31, 2021 | 402.70M | 235.30% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biomea Fusion | 200.21M |
| Outlook Therapeutics | 199.42M |
| Inhibrx | 196.95M |
| Renovaro Biosciences | 196.18M |
| Candel Therapeutics | 194.90M |
| Fractyl Health | 194.46M |
| XBiotech | 194.01M |
| 908 Devices | 192.43M |